Skip to main content
. 2024 Feb 4;15(6):1770–1778. doi: 10.7150/jca.90620

Figure 2.

Figure 2

The effect of acircRNAs inhibiting β-catenin and NF-κB in bladder cancer cells. (A) The description of working mechanism about transcript factor-related luciferase reporters. (B) The related expression of β-catenin detected using ELISA assay in SV-HUC1, T24 and 5637 cells. (C) The related expression of NF-κB detected using ELISA assay in SV-HUC1, T24 and 5637 cells. (D) Inhibition of β-catenin by different combination strategies of β-catenin aptamers in T24 cells. (E) Inhibition of β-catenin by different combination strategies of β-catenin aptamers in 5637 cells. (F) Inhibition of NF-κB by different combination strategies of NF-κB aptamers in T24 cells. (G) Inhibition of NF-κB by different combination strategies of NF-κB aptamers in 5637 cells. Results are shown as mean±SD. ***P < 0.001 compared with SV-HUC1. **P < 0.01 compared with SV-HUC1. *P < 0.05 compared with SV-HUC1.